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Abstract
Cytochrome c oxidase (CcO) reconstituted into phospholipid vesicles and subject to a membrane potential, exhibits different
characteristics than the free enzyme, with respect to effects of mutations, pH, inhibitors, and native structural differences between CcO from
different species. The results indicate that the membrane potential influences the conformation of CcO and the direction of proton movement
in the exit path. The importance of the protein structure above the hemes in proton exit, back leak and respiratory control is discussed.
D 2002 Elsevier Science B.V. All rights reserved.
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1. Introduction
Cytochrome c oxidase (CcO) functions as an energy
transducer, using the potential energy of electron transfer
to move protons across the membrane against an electro-
chemical gradient. The stoichiometry of one proton pumped
per electron transferred from cytochrome c suggests that
there is, normally, tight coupling between the two processes.
However, it has been difficult to determine how the two
events are coupled. In the simpler proton pump, bacterio-
rhodopsin (BR), the steps of proton transfer have been more
clearly delineated. Using the energy from light excitation, an
initial conformational change at the retinal releases the
proton into a hydrogen-bonded channel in which slight shifts
in pKa and water organization allow the release of the proton
to the solvent by way of two glutamates [1,2]. Interestingly,
no proton channel through the protein is seen on the proton
uptake side in the crystal structure. But after proton release
on the exit side (in microseconds), conformational changes
and water movement generates a proton uptake path [3]. In
CcO, there is also a fairly obvious water-containing proton
channel from the inner side of the membrane up to a buried
glutamate (E286), in this case used for proton uptake (Fig.
1). However, the pathway does not appear to connect to the
region above the hemes, where release of protons to the
outside must occur. As in BR, it seems likely that conforma-
tional change may influence that connection between the
interior and exterior in CcO and hence the exit route for
protons. In this paper, we consider the behavior of native and
mutant forms of CcO in the reconstituted state under the
influence of a membrane potential. The effects of protein
structure, pH and zinc on activity in this controlled state
suggest a membrane potential-induced conformation of CcO
that modulates proton movement in the exit path and the rate
of oxygen consumption. The implications for the mechanism
and regulation of proton pumping are discussed.
2. Evidence for conformation changes in oxidase
Measurements on reconstituted CcO show that proton
pumping is only observed when the membrane potential is
removed by addition of valinomycin. Under the influence of a
high DpH (acid outside) and high DC (positive outside),
activity is low and there is no proton pumping, but rather
protons move back into the interior of the vesicles, observed
on the outside as alkalinization. This controlled state is
assumed to be similar to state 4 respiration measured in
mitochondria, usually considered to be regulated by a slow
back leak of protons through the membrane [4]. However,
evidence now suggests [5] that back leak through the CcO
protein is an even larger contributor to the controlled activity.
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Evidence for a different conformation of the oxidase in
the controlled state comes from the observation that zinc
inhibits at a specific site on the outside of Rhodobacter
sphaeroides CcO with high affinity only in the presence of
a membrane potential [5]. This differential inhibition of the
controlled state results in a greatly increased RCR (as high
as 40) (Table 1). The data suggest that in the controlled
state, zinc prevents protonation (from the outside) of a site
that controls electron transfer; this could be the same site
that is modulated by changes of pH on the outside (Fig.
2A; and see below). This observation compares with
inhibition by zinc of certain voltage-gated channels in the
presence of a membrane potential which induces a partic-
ular conformational state [6,7]. It is suggestive that CcO
may also have a voltage-sensing element that regulates
activity by a conformational change under high potential
conditions, reflected as both a change in zinc binding and a
change in pH sensitivity (Fig. 2A) relative to the uncon-
trolled state.
3. Direction of proton movement
The proton uptake paths in oxidase were fairly clearly
seen in the first crystal structures and correlated well with
data from mutational studies, from which the names D (for
the asp132), K (lys362) channels were derived [8–11].
Mutations of aspartate 132 in R. sphaeroides CcO lead to
low activity (f5% wild type) [12]. In these mutants,
evidence suggests that the remaining activity is due to
protons moving preferentially from the outside in, rather
than the inside out, since highest activity is seen when a
membrane potential (positive outside) is present [12–15].
Significant proton uptake from the outside is also consistent
with the lack of observable proton pumping. A 10-fold
increase in activity and more normal respiratory control is
achieved by the addition of long-chain fatty acids [12,16].
This chemical rescue of the deleted aspartate with a hydro-
phobically tethered carboxyl suggests that the precise posi-
tion of the D-path carboxyl is not critical. Indeed the D132E
mutant shows almost wild-type activity under many con-
ditions [17]. However, even in the presence of the fatty acid,
no proton pumping is observed with D132A, suggesting that
under these conditions, reversal of the D path is kinetically
competitive with the forward direction [12].
When glutamate 286, which appears to represent the
buried end of the D path between the two hemes, is
mutated to a non-carboxylic amino acid, more inhibited
electron transfer results ( < 0.05% wild type) [16]. Even the
conservative mutation to an aspartate results in much
decreased activity and a markedly lowered deuterium
isotope effect (KIE of 7 to 2) [18]. Yet, as in the case of
D132A, when reconstituted into vesicles, the activity of
E286Q is highest under controlled conditions,f0.5% of
wild type at pH 6.5 (Table 2). This gives rise to the same
phenomenon of reverse respiratory control for E286Q
(controlled activity>uncontrolled activity) as seen with
Fig. 1. The R. sphaeroides CcO structure clearly shows two probable proton
paths through half of the membrane-spanning region, the D path (orange
arrow) and K path (blue arrow). A dotted black arrow depicts one proposed
route for protons from E286. Selected amino acid residues are named.
Coordinates generously provided by M. Svensson-Ek, L. Rodgers, J.
Abramson, S. Tonroth, P. Brzezinski and S. Iwata, personal communication.
The figure was made using Rasmol.
Table 1
Respiratory control varies as a function of protein structure in oxidases from
different sources and in site-directed mutants
Structural change Mutant R. sphaeroides
CcO or other oxidase
RCR
Proton uptake inhibited K362M 1–2
D132A < 1a
E286Q < 1
Electron input inhibited M263LII 2–3a
W143FII 2
Proton exit (?) inhibited R481K 20–35a
Zinc added 30–40a
Native oxidase variants Rhodobacter sphaeroides aa3 5–15
E. coli bo3 3–5
b
Thermus thermophilus ba3 40–50
c
All other data are previously unpublished. Measurements of RCR as
described in the legend to Fig. 2.
a Ref. [5].
b Ref. [46].
c Ref. [47].
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the D132A mutant. However, addition of arachidonic acid
is unable to rescue the activity, presumably because the
carboxyl group of the long-chain fatty acid cannot access
the site of the internally located E286Q. The simplest
interpretation from this data is that protons from the outside
stimulate the activity of E286Q (and D132A/N) by access-
ing a site external to the mutated positions that is required
to be protonated at some stage(s) in the catalytic cycle to
allow electron transfer to proceed. The data from these D-
path mutants suggest that when the D path is strongly
compromised, protons supplied from the outside at a slow
rate become important contributors to the controlled activ-
ity. In some forms of oxidase (E. coli bo3), D-path mutants are not so compromised and the phenomenon of reverse
RCR is not observed [19,20].
An analogous situation may be operative in the con-
trolled state of the wild-type CcO. The uptake of protons
into the D path is presumably slowed, as in a D-path mutant,
due to the imposed potential gradient. Uptake of protons
from the outside may then make the controlled activity at
least partly dependent on reversal of the exit path. This
would explain the lack of net gain of protons on the outside
in the controlled state, seen as a lack of proton pumping.
Also explained is the observation that increasing the outside
pH in stopped-flow experiments much more severely inhib-
its the controlled rate than the uncontrolled rate (Fig. 2A)
[21]. This results in large increases in respiratory control at
high pH in both mutants and wild-type CcO (Fig. 2B). It
should be noted that K-path mutants do not exhibit reverse
respiratory control, indicating that the site or sites supplied
by that path cannot be accessed from the outside, confirm-
ing the lack of involvement of K-path protons in the
pumping process.
The ability of protons to move into the oxidase from the
outside leads to the fundamental question of what is the
mechanism to ensure productive proton pumping against the
electrochemical gradient, and how far do the protons have to
go back to support uncoupled activity. The results with the
D132 and E286 mutants suggest that protonation of a
group(s) above E286 can stimulate activity, but the very
low rates with E286Q may nevertheless indicate that sig-
nificant increase in activity requires the participation of
E286 in mediating backflow.
4. When is proton release rate limiting?
There is considerable evidence that proton uptake via D-
and K-pathways is rate limiting in cytochrome oxidase in
the uncontrolled/free enzyme state. It is well established that
the K proton path is important for efficient reduction of
heme a3 [14,22–28]. Recent data show that the mutant
K362M (K354M in Paracoccus CcO) inhibits input of the
first electron [26,29] and may inhibit further steps in the
catalytic cycle [30]. Mutations in the D pathway inhibit
input of the second electron [29], but FTIR evidence
suggests that E286 remains protonated in oxidized and
Table 2
Mutations in the D path cause reverse respiratory control
COVs Activity (e /s/aa3) RCR
Controlled +Valinomycin Uncontrolled
Wild type 77F2 230F20 440F60 5.8
E286Q 0.44F0.01 0.17F0.02 0.26F0.02 0.59
D132A 23F1 5.6F0.05 15F1 0.65
Cytochrome c oxidation rates were measured using an Olis-rsm stopped-
flow with 4 AM pre-reduced horse-heart cytochrome c and COVs made by
dialysis [53,54] with 0.1 AM aa3 in 50 mM MES–KOH pH 6.5, 11 mM
KCl.
Fig. 2. The activity of CcO in the controlled state is strongly pH dependent.
The cytochrome c oxidation rate of CcO reconstituted into vesicles by the
dialysis method [53,54] was measured (average of three data sets) in an
Olis-rsm stopped-flow. (A) (n) Wild-type uncontrolled state (with 1 AM
valinomycin and 6 AM FCCP), (5) wild-type controlled state. All
measurements were made with 0.1 AM aa3 in vesicles and 4 AM cyt. c2+
giving 10 turnovers in 50 mM of MES–KOH, HEPES–KOH, CHES–
KOH or glycylglycine keeping ionic strength constant at 45 mM K+ and
with an internal buffer of 75 mM HEPES–KOH pH 7.4. (B) Measurements
of RCR (uncontrolled rate)/(controlled rate) were made for (n) wild-type,
(.) R481K, and (E) D132A mutants.
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reduced states [31,32]. This raises the question of what other
sites in the proton pumping pathway could be involved in
protonation/deprotonation reactions and contribute to con-
trolling the proton/electron flow.
The heme propionates, or the arginines that hydrogen
bond to them (R481, R482), have been proposed as such
sites [32–37]. Conservative mutations of these arginines to
lysines have been made, resulting in a limited effect on
activity [37–39]. However, the R481K mutation has an
unusually high RCR due to its low activity under controlled
conditions (Table 1, Fig. 2B; [38]). This suggests that the
mutation has made it more difficult for CcO to release or
take up a proton against an electrochemical gradient,
although normal activity and proton pumping is observed
when the membrane potential is removed. The data raise the
possibility that the mutant R481K is affecting protonation of
a site in the region above the hemes, such as one or more of
the heme propionates [33,37,40]. Since conservative
mutants are still able to pump protons [33,37,38], R481 is
unlikely to be the key protonatable site itself and is not close
enough to the bulk solvent to be the final release site for
protons.
Propionates play a role in the redox behavior of hemes
and can be quite mobile [41]. Small changes in the con-
formation and protonation of the propionates in CcO may be
contributory to redox potential changes of heme a and heme
a3 [40]. If the deprotonation of one or more propionates
occurs in the reaction cycle, this could be rate limiting and
give rise to a high deuterium kinetic isotope effect (KIE)
that is lowered if proton movement is delayed at an earlier
step. Indeed, it is observed that a high KIE for the Ferryl to
Oxidized (F to O) step of the cycle is significantly lowered
with the E286D mutant [42], consistent with the idea that
deprotonation of a group exterior to E286 is limiting for
CcO in this step.
The high KIE (f7) in the F!O step of the reaction
cycle in the four-electron reduced CcO suggests that proton
release is the rate-determining step in the last electron
transfer from CuA to the binuclear center [42]. Similarly, a
high KIE is observed in the L to M transition in BR where
proton release to the bulk solvent occurs, whereas proton
uptake has a small KIE of 1.6 [43,44].
5. What determines the RCR?
Measurement of the RCR is often used as a method of
checking whether reconstitution of CcO into vesicles has
been successful. However, with low-activity mutants where
the maximal uncontrolled rate is limited by proton uptake or
electron input, the RCR is often low, with certain D-path
mutants exhibiting a reverse RCR of less than 1 (Table 1).
Other mutants, with close to normal activity, have an
abnormally high RCR, such as R481K [5], whose behavior
is similar to zinc-inhibited wild-type CcO (Table 1). Both
the mutation and zinc binding are on the outside of the
enzyme where proton exit must occur, suggesting that
limitation of proton movement in the exit path above the
hemes can inhibit the controlled rate and thus increases the
RCR.
Given the results reviewed here, discrepancies in respi-
ratory control between oxidases derived from different
species (Table 1) may be explained in terms of structural
differences in the external regions of these CcOs, rather than
technical difficulties in reconstitution. Some, like the Para-
coccus denitrificans aa3, have low respiratory control
(RCR= 3–5) [45,46], while others, like T. thermophilus
ba3, have high respiratory control (RCR= 40) [47]. Another
structural change which likely affects this region due to
strong ionic interactions with both subunits II and I, is
removal of subunit III from CcO; this also results in high
RCR [48] (J. Hosler, D.A. Mills, and S. Ferguson-Miller,
unpublished data). Adjustment of the structure above the
hemes may be a method that CcO uses to regulate its
activity and control the efficiency of energy transduction
by modulating proton back leak. In the case of the mamma-
lian CcO, conformational modifications by small subunits
and nucleotide binding could cause allosteric changes in a
similar way [49,50].
6. Conclusions
The accumulated data from studies of BR and CcO sug-
gest that the movement of protons and their directionality
depends on small conformational changes that may affect the
pKs of key residues in a proton path or the formation/dis-
solution of water chains as demonstrated for BR. In CcO,
conformational changes (some too subtle to observe at the
structural resolution available) are expected to be associated
with electron transfer events and changes in oxygen reduc-
tion intermediates at the catalytic site, as well as the imposi-
tion of an electrical potential/pH gradient across the mem-
brane. It is probably important that E286, a key player in
proton movement, is joined in a loop to the Y288–His284
covalent pair which, in turn, interacts with heme a3/CuB and
can register redox changes at the active site during oxygen
reduction chemistry.
In CcO, the region above the hemes contains a significant
amount of ordered water, but no exit path for protons has yet
been defined and obvious ones [11] appear discontinuous in
current structures (Yoshikawa, personal communication).
Mutation of residues in this area has relatively subtle effects
on activity [37,51,52]. However, their ability to markedly
alter respiratory control and the pH dependence of con-
trolled activity suggests that structural changes above the
hemes may be critical in regulating CcO activity.
Finding the important residues in the region above the
hemes, and defining the conformational changes that likely
occur in each step of the catalytic cycle, will be crucial in
determining the mechanism and regulation of cytochrome
oxidase activity.
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